critically ill patients – Communicable Diseases Research

Anxiety and depression in the post-pandemic era: concerns about viral mutation and re-outbreak

Article

Published on 2022-11-032022-11-16
Journal: BMC Psychiatry
[Category] SARS, 변종,

Coronavirus disease 2019 subphenotypes and differential treatment response to convalescent plasma in critically ill adults: secondary analyses of a randomized clinical trial

Article

Published on 2022-11-012022-11-15
Journal: Intensive care medicine
[Category] Fulltext, MERS, 바이오마커,

[키워드] ABO-compatible convalescent plasma Adaptive platform trial Adults analysis assigned Biomarker Biomarkers chemokines community-acquired pneumonia convalescent plasma Convalescent plasma therapy coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient Critically ill critically ill patients Cytokines difference effector immune responses elevated endothelial explain heterogeneous homogeneous Hypothesis immunologically immunotherapies Inflammation IQR median multifactorial organ support outcome outcomes patients Population precision medicine Prevalence Randomized randomized clinical trial RCT RCTs REMAP-CAP reported secondary analysis Subphenotypes. tested therapy treatment effect Treatment response usual care with COVID-19
[DOI] 10.1007/s00134-022-06869-w PMC 바로가기

Prevalence and coagulation correlation of anticardiolipin antibodies in patients with COVID-19

Article

Published on 2022-10-142022-11-15
Journal: Medicine
[Category] 진단,

Reliability and clinical correlations of semi-quantitative lung ultrasound on BLUE points in COVID-19 mechanically ventilated patients: The ‘BLUE-LUSS’-A feasibility clinical study

Article

Published on 2022-10-142022-11-16
Journal: PLoS ONE
[Category] COVID19(2023년), SARS, 치료기술,

Acute kidney injury in critically ill COVID-19 infected patients requiring dialysis: experience from India and Pakistan

Article

Published on 2022-09-082022-11-16
Journal: BMC Nephrology
[Category] SARS, 치료기술,

Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock-a two-centre randomised clinical trial

Randomized Controlled Trial

Published on 2022-09-052022-10-05
Journal: Critical Care
[Category] 임상,

[키워드] Acute kidney injury Adequate Adult patient antibiotic Antibiotics clinical Clinical decision support clinical trial control group COVID-19 pandemic Critically ill patient critically ill patients data-driven dose Efficacy eligible Endpoint EudraCT European evaluate faster feasibility feasible for inclusion ICU implementation IMPROVE incidence Inclusion increased mortality Infection intervention group Lactate Mortality Netherland not significantly different outcome patients personalised pharmacokinetic pharmacokinetics Primary outcome randomisation randomised Registered renal right Safe Sepsis Septic shock significantly Support Therapeutic Drug Monitoring Therapeutic drug monitoring. Trial was obtained
[DOI] 10.1186/s13054-022-04098-7 PMC 바로가기 [Article Type] Randomized Controlled Trial

COVID-19 induced Diabetes: A novel presentation

Review article

Published on 2022-09-012022-10-05
Journal: Diabetes research and clinical practice
[Category] SARS, 유전자 메커니즘, 진단, 치료기술,

[키워드] affected assumed Atypical Beta cells biochemical biochemical pathway Case series cause caused Cell cell damage Complication COVID COVID-19 COVID-19 pandemic COVID-19 patient critically ill patients Cross-sectional studies detect diabete diabetes Diabetes Mellitus Diagnosis Diagnostic Criteria dysregulation Follow-up Glucose Google Scholar homeostasis implication include Infection insulin resistance management mechanisms meta-analyses Mortality mortality rate outcome parameter Pathogenesis pathophysiological mechanism Patient Prognosis Result risk factor SARS-CoV-2 significantly higher trajectory type 2 diabetes was performed
[DOI] 10.1016/j.diabres.2022.110034 [Article Type] Review article

Reactivation of EBV and CMV in Severe COVID-19-Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients

심각한 COVID-19-Epiphenomena에서 EBV 및 CMV의 재활성화 또는 치료가 필요한 Hyperinflammation의 트리거? 중환자의 대규모 사례 시리즈

Article

Published on 2022-09-012022-09-11
Journal: Journal of Intensive Care Medicine
[Category] 치료기술, 치료제,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 analyzed ARDS Chain Reaction Characteristics Clinical deterioration CMV cohort study comparable connection control group coronavirus Corticosteroid Course COVID-19 Critically ill Critically ill patient critically ill patients cytomegalovirus decrease described Diagnosis disease EBV Epstein-Barr virus Follow-up analysis Ganciclovir high risk hyperinflammation ICU in viral incidence increased mortality initiation of treatment intensive care intensive care unit intensive care unit. majority Non-COVID-19 non-COVID-19 patient Non-COVID-19 patients outcome Patient polymerase chain polymerase chain reaction Reactivation remains uncertain retrospective rituximab SARS-CoV-2 screened Sepsis sepsis patient Sery severe acute respiratory syndrome Coronavirus severe COVID-19 single-center survived systemic corticosteroid treated Treatment Trigger Viral load viral reactivation virus virus with COVID-19
[DOI] 10.1177/08850666211053990 PMC 바로가기 [Article Type] Article

Effect of interleukin-6 receptor antagonists in critically ill adult patients with COVID-19 pneumonia: two randomised controlled trials of the CORIMUNO-19 Collaborative Group

COVID-19 폐렴이 있는 위독한 성인 환자에서 인터루킨-6 수용체 길항제의 효과: CORIMUNO-19 공동 그룹의 2건의 무작위 대조 시험

Article

Published on 2022-08-102022-09-11
Journal: The European Respiratory Journal
[Category] Fulltext, SARS, 임상,

[키워드] 95% CI antagonist anti-IL-6 receptor assigned Bayesian clinical trials clinically controlled clinical trials coronavirus disease Coronavirus disease 2019 COVID-19 credible interval CrI Critically ill Critically ill patient critically ill patients determine Effect events group hazard ratio IMPROVE indicated interleukin-6 receptor intravenously investigator-initiated mechanical ventilation median multicentre NIV Noninvasive ventilation not need numbers of patient Open-label outcome Patient patients with COVID-19 Pneumonia posterior probability randomised randomised controlled randomised controlled trial Randomly receive receptor risk of death SARI sarilumab significantly TCZ TOCI Tocilizumab Trial usual care with COVID-19
[DOI] 10.1183/13993003.02523-2021 PMC 바로가기 [Article Type] Article

Reply – Letter to the editor: Nutritional management and clinical outcome of critically ill patients with COVID-19: A retrospective study in a tertiary hospital

Comment

Published on 2022-08-012023-07-09
Journal: Clinical nutrition (Edinburgh, Scotland)
[Category] COVID19(2023년),

[키워드] COVID-19 critically ill patients Nutritional medical therapy outcome.
[DOI] 10.1016/j.clnu.2022.06.019 PMC 바로가기 [Article Type] Comment